Expert Scientific Writing & Editing Services for your Manuscripts & Grants
Start a conversation: editors@lifescienceeditors.com
High quality scientific editing, writing, strategic insight, and advice on your communication, from editors who know the peer review process inside & out.
Harness our Unparalleled Team of Former Journal Editors, Grants Specialists, Language Editors, Writers, and Illustrators. We are committed to your success!
Testimonials
Guy Riddihough was an outstanding editor at Science Magazine. Now, all of his experience is with Life Science Editors. I had an enormously positive experience with Guy in completing our last manuscript for submission. I will be back.
Angela made the impossible possible. Thanks to her knowledge and effective communication skills, she helped us put together an R01 submission within a month of the deadline. This grant has also been funded at first submission. This experience convinced me that a team approach with Angela is the way forward in submitting grants!
Selected Edits
Single-cell nuclear architecture across cell types in the mouse brain.
Takei Y, Zheng S, Yun J, Shah S, Pierson N, White J, Schindler S, Tischbirek CH, Yuan GC, Cai L. Science. 2021 Sep 30 doi: 10.1126/science.abj1966.
Association of Rideshare Use With Alcohol-Associated Motor Vehicle Crash Trauma
Conner CR, Ray HM, McCormack RM, Dickey JS, Parker SL, Zhang X, Vera RM, Harvin JA, Kitagawa RS.
JAMA Surg. 2021 Jun 9:e212227. doi: 10.1001/jamasurg.2021.2227.
Why Us? We know how manuscripts, grant proposals and job candidates are evaluated. We have worked at:
-
Science Journals
Science
Science Translational Medicine -
Cell Press Journals
Cell
Cancer Cell
Molecular Cell
Cell Chemical Biology
Developmental Cell
Cell Reports
Cell Stem Cell
Trends in Cell Biology
Structure -
Nature Journals
Nature
NSMB
Nature Medicine
Nature Communications -
Academia & Biotech
Harvard University
EMBL
UCSF
Oxford University
Stanford
MRC
Huntsman Cancer Institute
IMBA
MIT/Broad Institute
NKI
Vall d’Hebron Institute
Helmholtz Institute
Arc
FMI
Recursion Pharmaceuticals